Resapp Health Ltd
ASX:RAP
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
AU |
Resapp Health Ltd
ASX:RAP
|
176.2m AUD | -43.3 | ||
US |
Veeva Systems Inc
NYSE:VEEV
|
32.4B USD | 31.1 | ||
US |
Cerner Corp
NASDAQ:CERN
|
27.9B USD | 16.9 | ||
US |
Change Healthcare Inc
NASDAQ:CHNG
|
9B USD | 20 | ||
JP |
M3 Inc
TSE:2413
|
1.3T JPY | 18.6 | ||
AU |
Pro Medicus Ltd
ASX:PME
|
11.4B AUD | 158.2 | ||
US |
Inspire Medical Systems Inc
NYSE:INSP
|
7B USD | 266 | ||
US |
Doximity Inc
NYSE:DOCS
|
4.4B USD | 22.3 | ||
SE |
Sectra AB
STO:SECT B
|
42.7B SEK | 73.1 | ||
US |
Evolent Health Inc
NYSE:EVH
|
3.1B USD | 24.9 | ||
US |
Goodrx Holdings Inc
NASDAQ:GDRX
|
2.8B USD | 20.3 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.